Bosi E
Bosi E
San Raffaele University Hospital
Verified email at
Cited by
Cited by
The CTLA-4 Gene Region of Chromosome 2q33 Is Linked to, and Associated with, Type 1 Diabetes
L Nisticò, R Buzzetti, LE Pritchard, B Van der Auwera, C Giovannini, ...
Human molecular genetics 5 (7), 1075-1080, 1996
Effects of vildagliptin on glucose control over 24 weeks in patients with type 2 diabetes inadequately controlled with metformin
E Bosi, RP Camisasca, C Collober, E Rochotte, AJ Garber
Diabetes care 30 (4), 890-895, 2007
Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring
D Deiss, J Bolinder, JP Riveline, T Battelino, E Bosi, N Tubiana-Rufi, ...
Diabetes care 29 (12), 2730-2732, 2006
Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice.
S Trembleau, G Penna, E Bosi, A Mortara, MK Gately, L Adorini
The Journal of experimental medicine 181 (2), 817-821, 1995
International consensus on use of continuous glucose monitoring
T Danne, R Nimri, T Battelino, RM Bergenstal, KL Close, JH DeVries, ...
Diabetes care 40 (12), 1631-1640, 2017
Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study
G Calori, G Lattuada, L Piemonti, MP Garancini, F Ragogna, M Villa, ...
Diabetes care 34 (1), 210-215, 2011
Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies.
E Bonifacio, V Lampasona, S Genovese, M Ferrari, E Bosi
The Journal of Immunology 155 (11), 5419-5426, 1995
Increased intestinal permeability precedes clinical onset of type 1 diabetes
E Bosi, L Molteni, MG Radaelli, L Folini, I Fermo, E Bazzigaluppi, ...
Diabetologia 49 (12), 2824-2827, 2006
Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity
E Bonifacio, S Genovese, S Braghi, E Bazzigaluppi, Y Lampasona, ...
Diabetologia 38 (7), 816-822, 1995
Insulin VNTR allele-specific effect in type 1 diabetes depends on identity of untransmitted paternal allele
ST Bennett, AJ Wilson, L Esposito, N Bouzekri, DE Undlien, F Cucca, ...
Nature genetics 17 (3), 350-352, 1997
High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes
R Buzzetti, S Di Pietro, A Giaccari, A Petrone, M Locatelli, C Suraci, ...
Diabetes Care 30 (4), 932-938, 2007
Vildagliptin plus metformin combination therapy provides superior glycaemic control to individual monotherapy in treatment‐naive patients with type 2 diabetes mellitus
E Bosi, F Dotta, Y Jia, M Goodman
Diabetes, Obesity and Metabolism 11 (5), 506-515, 2009
Fatty liver index and mortality: the Cremona study in the 15th year of follow‐up
G Calori, G Lattuada, F Ragogna, MP Garancini, P Crosignani, M Villa, ...
Hepatology 54 (1), 145-152, 2011
Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity
MR Christie, S Genovese, D Cassidy, E Bosi, TJ Brown, M Lai, ...
Diabetes 43 (10), 1254-1259, 1994
Distinct cytoplasmic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus
S Genovese, E Bonifacio, JM McNally, BM Dean, R Wagner, E Bosi, ...
Diabetologia 35 (4), 385-388, 1992
Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adult-onset autoimmune diabetes: Non Insulin Requiring Autoimmune …
V Lampasona, A Petrone, C Tiberti, M Capizzi, M Spoletini, S Di Pietro, ...
Diabetes care 33 (1), 104-108, 2010
Comparison of vildagliptin and metformin monotherapy in elderly patients with type 2 diabetes: a 24‐week, double‐blind, randomized trial
A Schweizer, S Dejager, E Bosi
Diabetes, Obesity and Metabolism 11 (8), 804-812, 2009
Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range
T Battelino, T Danne, RM Bergenstal, SA Amiel, R Beck, T Biester, E Bosi, ...
Diabetes Care 42 (8), 1593-1603, 2019
Metformin–the gold standard in type 2 diabetes: what does the evidence tell us?
E Bosi
Diabetes, Obesity and Metabolism 11, 3-8, 2009
Autoantibody response to islet transplantation in type 1 diabetes
E Bosi, S Braghi, P Maffi, M Scirpoli, F Bertuzzi, G Pozza, A Secchi, ...
Diabetes 50 (11), 2464-2471, 2001
The system can't perform the operation now. Try again later.
Articles 1–20